Transforming fee-for-service healthcare to connected and coordinated value-based healthcare takes teamwork. Medtronic and the Medical University of South Carolina (MUSC) recently announced a five-year healthcare collaboration to address the challenge. Initially, the work will focus on three value-based care programs related to vascular disease, joint replacement, and respiratory compromise.
For Medtronic, that focus means evolving to a value-based model of selling technologies, making the financial commitment that the technologies will actually deliver positive patient outcomes when used in the right way, on the right patients, at the right time in the care pathway. For MUSC, it means addressing challenging chronic disease statistics in new ways.
We can’t change the way healthcare is delivered without partners, without people who share the same vision.Omar Ishrak, chairman and CEO of Medtronic
MUSC and Medtronic are well-suited to one another. They share a common vision of value-based healthcare, can contribute complementary expertise, value the same attributes in a partner, and track insightful data.
“MUSC has a very sophisticated data structure, with access to information that makes them unique compared with other health systems,” said Christian Howell, vice president of value-based care programs at Medtronic. “Medtronic brings excellent clinical evidence and data from medical devices. Together we have the opportunity to create a really interesting health information exchange that can make a real difference to patients.”
The data will help them assess progress and will also be integrated into the care delivery process, enabling physicians and care teams to make more informed decisions.
The impact of the work could be far-reaching. “This work is transformational, where a health system and a technology and services leader are aligned on their strategic imperatives,” reflected Howell. “We are both focused on the health of the community, patient care, the cost of that care, and the satisfaction of the clinician.”